Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ROCKETDNA LTD. Director's Dealing 2026

Mar 23, 2026

65709_rns_2026-03-23_a5b518eb-68ce-4145-8559-a2f6c379330b.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity RocketDNA Ltd ABN 17 618 678 701

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Chris Clark
Date of last notice 24 December 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
-
Date of change 24 March 2026
No. of securities held prior to change 24,000,000 Performance Rights
2,000,000 Options expiring 30 May 2026
@ $0.021
10,357,133 Ordinary fully paid shares
10,000,000 Options Expiring 30 May 2029
@ $0.02
10,000,000 Options Expiring 30 May 2030
@ $0.03
10,000,000 Options Expiring 30 May 2031
@ $0.04
C & K CLARK SMSF PTY LTD
4,085,469 Ordinary fully paid shares
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class 1. Ordinary fully paid shares
2. Performance Rights
Number acquired 7,000,000 Ordinary fully paid shares
Number disposed 7,000,000 Performance Rights
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Nil
No. of securities held after change 17,000,000 Performance Rights
2,000,000 Options expiring 30 May 2026
@ $0.021
17,357,133 Ordinary fully paid shares
10,000,000 Options Expiring 30 May 2029
@ $0.02
10,000,000 Options Expiring 30 May 2030
@ $0.03
10,000,000 Options Expiring 30 May 2031
@ $0.04
C & K CLARK SMSF PTY LTD
4,085,469 Ordinary fully paid shares
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Exercise of Performance Rights with nil
exercise price
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the
trade to proceed during this period?
N/A
If prior written clearance was provided, on what date was
this provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3